Syros Pharmaceuticals Closes $53 Million Series B Financing

Includes Leading Public and Healthcare-Focused Funds

Proceeds Will Accelerate Gene Control Programs and Platform

WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--Syros Pharmaceuticals, a therapeutics company focused on discovering and develo...
Biopharmaceuticals, Venture Capital
Syros Pharmaceuticals